[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI72648B - Foerfarande foer framstaellning av fasta, laett resorberande och laongtidsverkande laekemedelspreparat innehaollande nifedipin. - Google Patents

Foerfarande foer framstaellning av fasta, laett resorberande och laongtidsverkande laekemedelspreparat innehaollande nifedipin. Download PDF

Info

Publication number
FI72648B
FI72648B FI812758A FI812758A FI72648B FI 72648 B FI72648 B FI 72648B FI 812758 A FI812758 A FI 812758A FI 812758 A FI812758 A FI 812758A FI 72648 B FI72648 B FI 72648B
Authority
FI
Finland
Prior art keywords
nifedipine
och
surface area
crystals
specific surface
Prior art date
Application number
FI812758A
Other languages
English (en)
Finnish (fi)
Other versions
FI812758L (fi
Inventor
Ahmed Hegasy
Klaus-Dieter Raemsch
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6111496&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI72648(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI812758L publication Critical patent/FI812758L/fi
Application granted granted Critical
Publication of FI72648B publication Critical patent/FI72648B/fi
Priority to FI893544A priority Critical patent/FI893544A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
FI812758A 1980-09-09 1981-09-07 Foerfarande foer framstaellning av fasta, laett resorberande och laongtidsverkande laekemedelspreparat innehaollande nifedipin. FI72648B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI893544A FI893544A0 (fi) 1980-09-09 1989-07-24 Anvaendning av specifika nifedipinkristaller foer framstaellning av fasta laett resorberande laekemedelspreparat med foerdroejd verkan.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803033919 DE3033919A1 (de) 1980-09-09 1980-09-09 Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
DE3033919 1980-09-09

Publications (2)

Publication Number Publication Date
FI812758L FI812758L (fi) 1982-03-10
FI72648B true FI72648B (fi) 1987-03-31

Family

ID=6111496

Family Applications (1)

Application Number Title Priority Date Filing Date
FI812758A FI72648B (fi) 1980-09-09 1981-09-07 Foerfarande foer framstaellning av fasta, laett resorberande och laongtidsverkande laekemedelspreparat innehaollande nifedipin.

Country Status (20)

Country Link
EP (1) EP0047899B2 (xx)
JP (1) JPS5914446B2 (xx)
AR (1) AR226377A1 (xx)
AT (1) ATE5761T1 (xx)
AU (1) AU558331B2 (xx)
CA (1) CA1180277A (xx)
DD (1) DD201974A5 (xx)
DE (2) DE3033919A1 (xx)
DK (1) DK154326C (xx)
FI (1) FI72648B (xx)
GR (1) GR78237B (xx)
HU (1) HU184879B (xx)
IE (1) IE51549B1 (xx)
IL (1) IL63749A (xx)
NO (1) NO157368B (xx)
NZ (1) NZ198285A (xx)
PH (1) PH24097A (xx)
PL (1) PL232951A1 (xx)
PT (1) PT73603B (xx)
ZA (1) ZA816213B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264446A (en) * 1980-09-09 1993-11-23 Bayer Aktiengesellschaft Solid medicament formulations containing nifedipine, and processes for their preparation
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
DE3222367A1 (de) * 1982-06-15 1983-12-15 Bayer Ag, 5090 Leverkusen Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung
JPS59101423A (ja) * 1982-12-02 1984-06-12 Takada Seiyaku Kk 新規なニフエジピン固形製剤
US4529733A (en) * 1983-04-06 1985-07-16 Merrell Dow Pharmaceuticals Inc. Antihypertensive 3-furoyl-1,4-dihydropyridines
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung
HU198844B (en) * 1984-06-14 1989-12-28 Sandoz Ag Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient
IT1178511B (it) * 1984-09-14 1987-09-09 Pharmatec Spa Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
US4940556A (en) * 1986-01-30 1990-07-10 Syntex (U.S.A.) Inc. Method of preparing long acting formulation
US5198226A (en) * 1986-01-30 1993-03-30 Syntex (U.S.A.) Inc. Long acting nicardipine hydrochloride formulation
CH673947A5 (xx) * 1986-09-23 1990-04-30 Sandoz Ag
JPS6464659A (en) * 1987-09-03 1989-03-10 Kenbi Kogaku Kenkyusho Kk Preparation of safe and effective powder formulation
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
DE3814532A1 (de) * 1988-04-29 1989-11-09 Bayer Ag Dhp-retard-zubereitung
JPH0298550U (xx) * 1989-01-25 1990-08-06
GB8903328D0 (en) * 1989-02-14 1989-04-05 Ethical Pharma Ltd Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
DE4130173A1 (de) * 1991-09-11 1993-03-18 Bayer Ag Pharmazeutische zubereitungen mit einer speziellen kristallmodifikation des 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarbonsaeure-isopropyl-(2-methoxyethyl)-esters
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5543099A (en) * 1994-09-29 1996-08-06 Hallmark Pharmaceutical, Inc. Process to manufacture micronized nifedipine granules for sustained release medicaments
DE59410044D1 (de) * 1994-12-29 2002-03-21 Shire Deutschland Gmbh & Co Kg Pharmazeutische zubereitungen, enthaltend nifedipin und verfahren zu ihrer herstellung
JP3220373B2 (ja) 1995-11-28 2001-10-22 バイエル薬品株式会社 持続性ニフエジピン製剤
US6093420A (en) 1996-07-08 2000-07-25 Edward Mendell Co., Inc. Sustained release matrix for high-dose insoluble drugs
IT1284604B1 (it) * 1996-09-27 1998-05-21 Roberto Valducci Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
WO2001022940A1 (en) 1999-09-30 2001-04-05 Edward Mendell Co., Inc. Sustained release matrix systems for highly soluble drugs
ATE512961T1 (de) 2004-07-30 2011-07-15 Torrent Pharmaceuticals Ltd Amorphes nebivolol hydrochlorid und seine herstellung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3330727A (en) * 1960-04-19 1967-07-11 Glaxo Lab Ltd Griseofulvin with high specific surface area
US3401221A (en) * 1964-08-25 1968-09-10 Norwich Pharma Co Treatment of urinary tract infection
DE2348334C2 (de) * 1973-09-26 1982-11-11 Boehringer Mannheim Gmbh, 6800 Mannheim Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N'-cyclohexylharnstoffs
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
JPS55129221A (en) * 1979-03-29 1980-10-06 Kaken Pharmaceut Co Ltd Preparation of oral preparation containing hardly soluble medicine
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material

Also Published As

Publication number Publication date
ZA816213B (en) 1982-09-29
NO812879L (no) 1982-03-10
AU558331B2 (en) 1987-01-29
DE3161838D1 (en) 1984-02-09
FI812758L (fi) 1982-03-10
DK396381A (da) 1982-03-10
DD201974A5 (de) 1983-08-24
HU184879B (en) 1984-10-29
NO157368B (no) 1987-11-30
AU7506381A (en) 1982-03-18
IL63749A (en) 1984-06-29
JPS5750913A (en) 1982-03-25
EP0047899B2 (de) 1996-02-28
DK154326C (da) 1995-03-13
JPS5914446B2 (ja) 1984-04-04
DE3033919A1 (de) 1982-04-22
NZ198285A (en) 1984-04-27
IL63749A0 (en) 1981-12-31
AR226377A1 (es) 1982-06-30
PL232951A1 (xx) 1982-10-11
IE51549B1 (en) 1987-01-07
IE812075L (en) 1982-03-09
ATE5761T1 (de) 1984-01-15
PH24097A (en) 1990-03-05
CA1180277A (en) 1985-01-02
PT73603A (en) 1981-09-01
DK154326B (da) 1988-11-07
PT73603B (en) 1982-11-10
GR78237B (xx) 1984-09-26
EP0047899B1 (de) 1984-01-04
EP0047899A1 (de) 1982-03-24

Similar Documents

Publication Publication Date Title
FI72648B (fi) Foerfarande foer framstaellning av fasta, laett resorberande och laongtidsverkande laekemedelspreparat innehaollande nifedipin.
US5264446A (en) Solid medicament formulations containing nifedipine, and processes for their preparation
FI82376C (fi) Foerfarande foer framstaellning av tvaofasiga, fasta laekemedelspreparat.
KR100353304B1 (ko) 맛이 차폐된 마이크로캡슐 조성물 및 이것의 제조 방법
RU1816213C (ru) Способ получени твердой лекарственной формы с регулируемым выделением лекарственного средства
FI116773B (fi) Menetelmä mykofenolaattimofetiilin oraalisten suurannossuspensioiden valmistamiseksi
KR100223131B1 (ko) 서방성 약제 용량 단위
DE3783332T2 (de) Spruehgetrocknetes acetaminophen.
AU642747B2 (en) Antimalarial compositions
JPH0737384B2 (ja) 経口投与用調合剤
NL8501578A (nl) Nieuwe galenische retardvorm.
CA1298199C (en) Spray dried acetaminophen
EP2854773B1 (en) Pharmaceutical composition of entecavir and process of manufacturing
DE69934781T2 (de) Morphinsulfat enthaltende mikrogranulate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen
JP5504312B2 (ja) 薄層糖衣錠およびその製造方法
EP1929997A1 (en) Oxcarbazepine formulations
EP0538034B1 (en) Taste mask coatings for preparing chewable pharmaceutical tablets
EP0473431B1 (en) Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
Jachowicz Dissolution rates of partially water-soluble drugs from solid dispersion systems. II. Phenytoin
KR100281521B1 (ko) 프라바스타틴나트륨이 함유된 약제 조성물
Chowdary et al. Controlled release of nifedipine from mucoadhesive tablets of its inclusion complexes with β-cyclodextrin
JPH05194233A (ja) マイクロペレットおよびそれらの製造方法
CN115124420B (zh) 大黄酸与苦参碱共晶物水合物及制备方法和其组合物与用途
GB2234898A (en) Oral pharmaceutical dosage form improving bioavailability
KR20080030835A (ko) 약학 조성물

Legal Events

Date Code Title Description
FC Application refused

Owner name: BAYER AKTIENGESELLSCHAFT